Alessa Therapeutics, Inc.
- 13/12/2024
- Seed
- $15,000,000
Alessa Therapeutics is developing localized treatments for solid organ disease.
- Industry Biotechnology Research
- Website https://alessatherapeutics.com/
- LinkedIn https://www.linkedin.com/company/alessa-therapeutics-inc/
Related People
Pamela N MunsterFounder
A native of Switzerland, I am a professor of medicine at the University of California San Francisco, where I am leader of the Experimental Therapeutics Program/Helen Diller Family Comprehensive Cancer Center, Director of The Early Phase Clinical Trials Unit, and coleader of the Center for BRCA Research. In addition to my clinical research, my laboratory based research, is focused on epigenetics and developing novel strategies to treat patients with incurable cancers. I have founded AlessaTherapeutics focused on the sustained localized delivery of anti-cancer agents and i have many years of experience in bringing novel cancer therapeutics into the clinic. I serve on multiple local, national, and international committees focused on developing new treatments for cancer and serve on the board of directors for private companies. As part as my academic focus i have authored textbooks and am a frequent lecturer. I am passionate about breast awareness with campaigns in the US, UAE, and India and have recently authored a book describing the challenges on living with cancer in Twisting Fate.